Global IVIG Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global IVIG Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
IVIG report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global IVIG market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Multiple Sclerosis(MS) and Myasthenia Gravis(MG) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for IVIG industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, IVIG key manufacturers include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. Green Cross, BSV, Hualan Bio are top 3 players and held % sales share in total in 2022.
IVIG can be divided into Injection IVIG and Lyophilized Powder IVIG, etc. Injection IVIG is the mainstream product in the market, accounting for % sales share globally in 2022.
IVIG is widely used in various fields, such as Multiple Sclerosis(MS), Myasthenia Gravis(MG), Multifocal Motor Neuropathy(MMN) and Multifocal Acquired Sensory and Motor Neuropathy(MADSAM), etc. Multiple Sclerosis(MS) provides greatest supports to the IVIG industry development. In 2022, global % sales of IVIG went into Multiple Sclerosis(MS) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global IVIG market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Segment by Type
Injection IVIG
Lyophilized Powder IVIG
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the IVIG market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of IVIG, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the IVIG industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of IVIG in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, IVIG introduction, etc. IVIG Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of IVIG market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for IVIG industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, IVIG key manufacturers include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. Green Cross, BSV, Hualan Bio are top 3 players and held % sales share in total in 2022.
IVIG can be divided into Injection IVIG and Lyophilized Powder IVIG, etc. Injection IVIG is the mainstream product in the market, accounting for % sales share globally in 2022.
IVIG is widely used in various fields, such as Multiple Sclerosis(MS), Myasthenia Gravis(MG), Multifocal Motor Neuropathy(MMN) and Multifocal Acquired Sensory and Motor Neuropathy(MADSAM), etc. Multiple Sclerosis(MS) provides greatest supports to the IVIG industry development. In 2022, global % sales of IVIG went into Multiple Sclerosis(MS) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global IVIG market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Segment by Type
Injection IVIG
Lyophilized Powder IVIG
Segment by Application
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the IVIG market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of IVIG, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the IVIG industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of IVIG in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, IVIG introduction, etc. IVIG Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of IVIG market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.